Skip to main content
InPharmacy - return to the homepage InPharmacy logo
  • Search
  • Visit InPharmacy on Linked In
  • Visit InPharmacy on Twitter
  • Visit InPharmacy on Facebook
  • Visit InPharmacy on YouTube
Visit the
National Pharmacy Association National Pharmacy Association

Main navigation

  • NPA News
  • Your Pharmacy
  • Member Benefits
  • Topics
Quick links:
  • Home
  • Categories
  • Your Pharmacy
  • Advice & Support
Patient Safety
NPA News

Medication safety officer report Q4 2018

Share on
  • Whatsapp
  • Twitter
  • Facebook
  • Linked in
  • Mail
  • Print
Open-access content Monday 4th March 2019 — updated 11.02am, Thursday 20th January 2022

NPA Director of Pharmacy, Leyla Hannbeck, is the Medication Safety Officer (MSO) for all English pharmacies with fewer than 50 branches. Here are some of the findings from the October to December (quarter 4) report.

Bottle of pills

NPA Director of Pharmacy, Leyla Hannbeck, is the Medication Safety Officer (MSO) for all English pharmacies with fewer than 50 branches. Here are some of the findings from the October to December (quarter 4) report.

Although the majority of the errors originated from the pharmacy,  3% of the errors reported were due to prescribing errors, especially after patients are discharged from hospital and their current prescription does not reflect changes made by the hospital.

Lookalike Sound-alike (LASA) errors

Please be aware if the “wrong strength” or “wrong formulation” has been selected, it is not considered a LASA error. The most common LASA errors reported in Quarter 4 of 2018 in the “wrong drug/medicine” category are listed in the table.

Sereflo inhalers 125mcg and 250mcg

The Community Pharmacy Patient Safety Group also highlighted a LASA error involving similar packaging of Sereflo inhaler (fluticasone/salmeterol inhaler CFC free) in the strengths of 125mcg and 250mcg manufactured by Cipla (UK) Ltd. The outer packaging for both strengths is almost identical in colour with a difference in the darker shade of purple tones for the higher strength. Following feedback from the NPA, MHRA said it is investigating the Sereflo issue and will be alerting manufacturers about their poor strength differentiation.

A child was given olanzapine orodispersible tablets instead of omeprazole dispersible tablets, in a rare yet serious LASA error. This led to hospitalisation after the child displayed signs of drowsiness following ingestion of three tablets.

Medication error category

Incidents reported as “wrong strength” (25%) involved gabapentin capsules 100mg and 300mg (5%) and clarithromycin tablets 250mg and 500mg (4%). Incidents reported as “wrong formulation” (9.2%) involved dispersible tablet preparations being dispensed incorrectly in place of capsules and/or tablets, and vice versa – for example, aspirin dispersible tablets dispensed instead of gastro-resistance tablets.

Contributing factors

Work and environment factors (47%) increased by 2% compared to Quarter 3 of 2018. This was because pharmacists were undertaking all tasks themselves. 21% of such incidents reported were due to staff shortages, leading to the pharmacist to solely carry out the dispensing process and self-checking. A total of 22% of self-checking incidents were where the “wrong strength” was dispensed.

Degree of harm

Errors resulting in “none” (58%) and “near miss” (30%) continue to be reported and these made up majority of reports. An incident which resulted in “severe harm” involved a patient being given an antibiotic (co-amoxiclav) and developed a skin rash, even though it was known to both the prescriber and pharmacist that the patient was severely allergic to penicillin.

Facts and figures

Errors involving the NHS flu vaccination service 2018/19

For the second report running, we have seen a high number of patient safety incidents relating to the NHS flu vaccination service 2018-19. It is prudent that all pharmacists undertaking the service read and understand what is outlined in the NHS flu Patient Group Direction (PGD) and service specification. This quarter, there were two incidents following Fluad being administered to multiple patients under 64 years of age, and multiple flu vaccines being administered to the same patient. 

Delivery drivers

Delivery errors accounted for 5% of incidents reported. This was a 2% increase from the previous quarter, which could be due to a higher number of patients preferring delivery over collections, and pharmacies delivering medicines, in the colder weather. 

Inhalers and nasal sprays

Prescriptions written generically for beclometasone and fluticasone inhalers have led to an increase in patient safety incidents with the nasal spray being dispensed instead and vice versa.

Short-dated stock

A handwritten hospital prescription for four bottles of Travatan eye drops for a duration treatment period of four months was received. Halfway through treatment, two bottles expired. When the pharmacist re-ordered, they received another set of very short-dated stock.      

Image credit | iStock

 
Topics:
Advice & Support
Patient Safety
NPA News

You might also like...

Today's top reads

Sign up to stay up to date

Subscribe

Why not become a member?

Find out more

Looking for a resource?

Read More
​
FOLLOW US
@NPA1921
National Pharmacy Association
National Pharmacy Association
CONTACT US
InPharmacy
Tel: (+44) 01727 858687
​

NPA

About NPA
Become a member
Services & Support
Events

Information

Privacy Policy
Terms & Conditions
Cookie Policy
Sign in or create an account

Get in touch

Contact us
Advertise with us
Write for InPharmacy

General

Pharmacy Careers
Business Partner
Insurance
Representing You

NPA InPharmacy Logotype

© 2022 • InPharmacy is produced by Redactive Media Group. All rights reserved. Reproduction of any part is not allowed without written permission.

Redactive Media Group Ltd, 71-75 Shelton Street, London WC2H 9JQ

 

 

  • Sign in
  • Create account
  • Business Support & Development
  • Learning & Development
  • Advice & Support
  • Insurance
  • Membership
  • Representing You
  • ADVICE AND SUPPORT
    • Key Notes
    • Patient Safety
    • Regulations and Legislation
    • Diary Dates
    • Pharmacy Services
  • BUSINESS SUPPORT & DEVELOPMENT
    • Technology & Data
    • Employment Law & HR
    • Health & Safety
    • Business Operations
    • Recommended Partners
  • LEARNING & DEVELOPMENT
    • Professional Development
    • You and Your Pharmacy Team
    • New Training Initiatives
  • INSURANCE
    • Business Insurance
    • Personal Insurance
    • Professional Indemnity
  • REPRESENTING YOU
    • Campaigns and lobbying
    • Opinions & Ideas